0001209191-18-041915.txt : 20180706 0001209191-18-041915.hdr.sgml : 20180706 20180706200244 ACCESSION NUMBER: 0001209191-18-041915 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180705 FILED AS OF DATE: 20180706 DATE AS OF CHANGE: 20180706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neff Thomas B CENTRAL INDEX KEY: 0001623238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 18943205 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-05 0 0000921299 FIBROGEN INC FGEN 0001623238 Neff Thomas B C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 1 1 0 0 Chief Executive Officer Common Stock 2018-07-05 4 M 0 10320 3.60 A 2839193 D Common Stock 2018-07-05 4 S 0 13500 63.97 D 2825693 D Common Stock 2018-07-05 4 S 0 5400 64.62 D 2820293 D Common Stock 2018-07-05 4 S 0 818 63.92 D 106828 I By Family Partnership Common Stock 2018-07-05 4 S 0 100 64.75 D 106728 I By Family Partnership Common Stock 2018-07-06 4 M 0 10320 3.60 A 2830613 D Common Stock 2018-07-06 4 S 0 1600 64.15 D 2829013 D Common Stock 2018-07-06 4 S 0 5940 65.24 D 2823073 D Common Stock 2018-07-06 4 S 0 8723 66.16 D 2814350 D Common Stock 2018-07-06 4 S 0 2637 66.96 D 2811713 D Common Stock 2018-07-06 4 S 0 600 65.61 D 106128 I By Family Partnership Common Stock 2018-07-06 4 S 0 318 66.80 D 105810 I By Family Partnership Common Stock 19500 I By Spouse Common Stock 60946 I See footnote Stock Option (Right to Buy) 3.60 2018-07-05 4 M 0 10320 0.00 D 2019-03-11 Common Stock 10320 319901 D Stock Option (Right to Buy) 3.60 2018-07-06 4 M 0 10320 0.00 D 2019-03-11 Common Stock 10320 309581 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $63.35 to $64.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $64.35 to $65.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $63.50 to $64.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $63.75 to $64.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $64.75 to $65.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $65.75 to $66.725. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $66.80 to $67.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $64.925 to $65.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $66.70 to $67.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP. Fully vested. /s/ Dorothy Pacini, Attorney-in-fact 2018-07-06